Evidence map›Paper›PMID 39011353›Full record

ArticleJournal of pharmaceutical policy and practice2024

Point prevalence survey of antibiotics use among hospitalised neonates and children in Saudi Arabia: findings and implications.

Hind M Alosaimi, Mohammed K Alshammari, Mohammad M Fetyani, Maha S Allehidan, Tahani J Almalki, Khansa H Hussain, Haifaa H Hussain, Mohammed D Althobaiti, Abrar S Alharbi, Atheer A Alharthi and 4 more

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. The association between parenteral antimicrobials and bacterial resistance at King Khaled Hospital in Al-Kharj: A retrospective cohort study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hind M AlosaimiDepartment of Pharmacy Services Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia.
Mohammed K AlshammariDepartment of Clinical Pharmacy, King Fahad Medical City, Kingdom of Saudi Arabia, Riyadh, Saudi Arabia.
Mohammad M FetyaniDepartment of Pharmacy Services, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia.
Maha S AllehidanDepartment of Pharmacy Services, NICU/Pediatric Clinical Pharmacist, Alyamam Hospital, Second Health Cluster, Riyadh, Saudi Arabia.
Tahani J AlmalkiPharmaceutical Care Administration, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia.
Khansa H HussainDepartment of Cardiac Science, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Haifaa H HussainDepartment of Nursing, Advanced Practice Nurse, Pediatric Nurse Practitioner, King Faisal Specialist Hospital and Research Center, Kingdom of Saudi Arabia, Riyadh, Saudi Arabia.
Mohammed D AlthobaitiDepartment of Medical Surgical Nursing, King Faisal Specialist Hospital & Research Center, Kingdom of Saudi Arabia, Riyadh, Saudi Arabia.
Abrar S AlharbiDepartment of Pharmaceutical Services, Maternity and Children's Hospital, West Zone, Kingdom of Saudi Arabia, Mecca, Saudi Arabia.
Atheer A AlharthiDepartment of Medicine, Taif University, Taif, Saudi Arabia.
Amosha A Al-ShammariDepartment of Pharmacy, Maternity and Children Hospital in Rafah, Kingdom of Saudi Arabia, Rafha, Saudi Arabia.
Zainab A Al JameaDepartment of Pharmaceutical Care, King Fahd Hospital of University, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
Rayed A AlamroDepartment of Pharmacy Services, Dr. Sulaiman Al Habib Medical Group Alrayyan Hospital, Riyadh, Saudi Arabia.
Ali NajmiPharmaceutical Care Administration, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Neonates and children are more susceptible to a variety of infections, leading to frequent antibiotic prescriptions. However, the inappropriate use of antibiotics leads to antibiotic resistance and higher mortality rates. Therefore, this study aimed to determine the prevalence of antibiotic use, and current antibiotic prescribing practices among neonates and children admitted in the selected hospitals of Saudi Arabia. Methods: A cross-sectional study was conducted from September to November 2023 to assess the prevalence of antibiotic use, and the current antibiotic prescribing practices across six hospitals of Saudi Arabia. Results: The study included 499 children and neonates, with 94.6% receiving antibiotic prescriptions. The most frequently prescribed antibiotic class was third-generation cephalosporin (31.5%), with ceftriaxone being the most commonly prescribed antibiotic (15%). The majority of patients were prescribed one antibiotic (81.4%), and the intravenous route (96.4%) was the primary route for administration. The majority of patients were prescribed antibiotics empirically (69.7%), and community-acquired infections (64.2%) were the most common type of infection for antibiotic prescription. Similarly, sepsis (39.2%) was the most common indication for antibiotics, and the majority of prescribed antibiotics (61.7%) belonged to the 'Watch' category as per WHO AWaRe classification. Conclusion: Our study revealed excessive antibiotic consumption in neonates and children, therefore quality improvement programmes including antimicrobial stewardship programmes are urgently needed to address ongoing issues.

Indexed as

Antibioticsantimicrobial resistanceAWaRe classificationchildrenpoint prevalence surveySaudi Arabia

Identifiers

PMID39011353
PMCPMC11249164

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.